Optimizing bone metabolism in osteoporosis: insight into the pharmacologic profile of strontium ranelate.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA

Volumn 14 Suppl 3, Issue , 2003, Pages

  Marie, P J ^a  

^a HÔPITAL LARIBOISIÈRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ORGANOMETALLIC COMPOUND; STRONTIUM RANELATE; THIOPHENE DERIVATIVE;

ANIMAL; ANIMAL MODEL; BONE DENSITY; BONE DEVELOPMENT; DRUG EFFECT; HAPLORHINI; HUMAN; MOUSE; OSTEOLYSIS; OSTEOPOROSIS; PATHOPHYSIOLOGY; PHYSIOLOGY; RAT; REVIEW;

ANIMALS; BONE DENSITY; BONE DEVELOPMENT; BONE RESORPTION; HAPLORHINI; HUMANS; MICE; MODELS, ANIMAL; ORGANOMETALLIC COMPOUNDS; OSTEOPOROSIS; RATS; THIOPHENES;

MLCS; MLOWN;

EID: 0141834674     PISSN: 0937941X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00198-002-1344-5     Document Type: Review

References (16)